SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-002033
Filing Date
2023-05-24
Accepted
2023-05-24 07:06:05
Documents
5
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 6-K zk2329789.htm 6-K 13070
2 REGISTRANT'S PRESS RELEASE DATED MAY 24, 2023; exhibit_1.htm EX-99 341616
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, exhibit_2.htm EX-99 312840
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF MARCH 31, 2023 AND FOR THE THR exhibit_3.htm EX-99 160890
5 image0.jpg GRAPHIC 9376
  Complete submission text file 0001178913-23-002033.txt   842569
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 23950583
SIC: 2834 Pharmaceutical Preparations